Literature DB >> 1372719

Safe introducer technique for pacemaker lead implantation.

C L Byrd1.   

Abstract

Over the last several years, an introducer approach for pacemaker lead insertion has evolved that eliminates most introducer-related complications. The approach consists of defining a safe region for intrathoracic cannulation of the subclavian vein. If specific conditions cannot be met for entering the "safe" region or if the vein cannot be found, the subclavian vein is cannulated extrathoracically. Recently, this technique was used in 263 consecutive patients undergoing pacemaker implantation. The intrathoracic portion of the subclavian vein was used in 239 (90.9%) cases and the extrathoracic portion in 24 (9.1%). One hundred and ninety-eight (75.3%) cases were right-sided and 65 (24.7%) were left-sided. On the right side, 177 (89.4%) used the intrathoracic portion of the subclavian vein and 21 (10.6%) used the extrathoracic portion. On the left side, 62 (95.4%) used the intrathoracic portion and three (4.6%) used the extrathoracic. The introducer technique was successful in all cases and there were no introducer-related complications.

Entities:  

Mesh:

Year:  1992        PMID: 1372719     DOI: 10.1111/j.1540-8159.1992.tb06494.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  Prospective study to develop surface landmarks for blind axillary vein puncture for permanent pacemaker and defibrillator lead implantation and compare it to available contrast venography guided technique.

Authors:  S Mehrotra; Manoj Kumar Rohit
Journal:  Indian Heart J       Date:  2015-05-13

2.  Pneumopericardium and Pneumomediastinum After Implantation of a Cardiac Resynchronization Pacemaker.

Authors:  Peregrine G Green; Neil Herring
Journal:  JACC Case Rep       Date:  2019-10

3.  Early-BYRD: alternative early pacing and defibrillation lead replacement avoiding venous puncture.

Authors:  Andreas Keyser; Simon Schopka; Carsten Jungbauer; Maik Foltan; Christof Schmid
Journal:  J Cardiothorac Surg       Date:  2018-10-03       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.